Aptus Capital Advisors LLC Has $23.58 Million Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Aptus Capital Advisors LLC increased its stake in Intuitive Surgical, Inc. by 9.4%, owning 47,608 shares valued at $23.58 million as of the end of the first quarter.
• Analysts have given Intuitive Surgical an average rating of "Moderate Buy," with a price target of $595.95 following several upward revisions from different research firms.
• Insider transactions included sales of nearly 15,839 shares by executives, indicating a notable 92.73% decrease in one executive's holdings after selling shares at an average price of $492.48.

Aptus Capital Advisors LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,608 shares of the medical equipment provider's stock after buying an additional 4,091 shares during the quarter. Aptus Capital Advisors LLC's holdings in Intuitive Surgical were worth $23,579,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Castleark Management LLC lifted its stake in Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after buying an additional 2,990 shares in the last quarter. Arlington Trust Co LLC increased its holdings in shares of Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares during the last quarter. Aveo Capital Partners LLC boosted its position in shares of Intuitive Surgical by 37.4% in the first quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock valued at $390,000 after acquiring an additional 198 shares during the period. Aaron Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after acquiring an additional 78 shares during the period. Finally, Longbow Finance SA lifted its holdings in shares of Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock worth $9,756,000 after acquiring an additional 11,209 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. BTIG Research upped their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Citigroup reissued a "buy" rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Royal Bank Of Canada increased their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a research report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $595.95.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Gary S. Guthart sold 7,893 shares of the business's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total value of $3,935,765.52. Following the transaction, the insider directly owned 13,187 shares of the company's stock, valued at $6,575,565.68. The trade was a 37.44% decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,839 shares of company stock valued at $7,896,972 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $480.26 on Monday. The stock has a market capitalization of $172.16 billion, a price-to-earnings ratio of 66.98, a PEG ratio of 5.03 and a beta of 1.59. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business's fifty day moving average is $508.75 and its 200-day moving average is $524.77.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.78 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.